Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2013
10/17/2013WO2013153179A1 Liposomes containing oligopeptide fragments of myelin basic protein, a pharmaceutical composition and a method for treatment of multiple sclerosis
10/17/2013WO2013153146A1 Aggregate particles
10/17/2013WO2013153145A1 Oral film containing opiate enteric-release beads
10/17/2013WO2013153111A1 Pharmaceutical composition containing an unsaturated fatty acid enriched with oxygen and an organic solvent
10/17/2013WO2013152838A1 Preparation for topical application to mucosa containing polyhexanide as active ingredient
10/17/2013WO2013152641A1 Lercanidipine hydrochloride and losartan potassium compound preparation and preparation method thereof
10/17/2013WO2013152418A1 System and method for multiphasic release of growth factors
10/17/2013WO2013124869A3 The art, method,manner process and system of fibrous bio-degradable polymeric wafers for the local delivery of therapeutic agents in combinations
10/17/2013WO2013106117A3 Nanoparticles for controlling bleeding and drug delivery
10/17/2013WO2013104995A3 Compositions and methods for treating viral infections
10/17/2013WO2012116402A9 Binder powders
10/17/2013WO2012051426A3 Aggregate nanoparticulate medicament formulations, manufacture and use thereof
10/17/2013US20130274694 Transdermal patch incorporating active agent migration barrier layer
10/17/2013US20130274689 Method for Reducing or Preventing Transplant Rejection in the Eye and Intraocular Implants for Use Therefor
10/17/2013US20130274651 System and method for improving outcome of cerebral ischemia
10/17/2013US20130274362 Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use
10/17/2013US20130274352 Oral Drug Devices and Drug Formulations
10/17/2013US20130274348 Orally disintegrating tablet
10/17/2013US20130274346 Pharmacologically optimized multimodal drug delivery system for nordihydroguiaretic acid (ndga)
10/17/2013US20130274342 Compositions and methods for treating cough
10/17/2013US20130274341 Methods and Compositions for Treatment of Dermal Conditions
10/17/2013US20130274339 Novel functional food product and method thereof
10/17/2013US20130274309 Compositions and methods for non-parenteral delivery of oligonucleotides
10/17/2013US20130274306 Treating inflammation and inflammatory pain in mucosa using mucosal prolonged release bioadhesive therapeutic carriers
10/17/2013US20130274302 Topical localized isoxazoline formulation comprising glycofurol
10/17/2013US20130274300 Extended Release Tablet Formulation Containing Pramipexole or a Pharmaceutically Acceptable Salt Thereof
10/17/2013US20130274280 Anti-abuse gelled pharmaceutical compositions
10/17/2013US20130274231 Compositions for use in treatment of dermatological diseases and conditions
10/17/2013US20130274217 Controlled Release Formulations for the Delivery of HIF-1 Inhibitors
10/17/2013US20130274192 Microparticles containing physiologically active peptide, method for preparing the same, and pharmaceutical composition comprising the same
10/17/2013US20130274180 Pharmaceutical Compositions
10/17/2013US20130273284 Biodegradable multi-block co-polymers
10/17/2013US20130273187 Method of treating acne
10/17/2013US20130273172 Topical pharmaceutical compositions containing nanodroplets for the treatment psoriasis
10/17/2013US20130273170 Puumala virus full-length m segment-based dna vaccines
10/17/2013US20130273169 Stable Solid Formulation of GC-C Receptor Agonist Polypeptide Suitable for Oral Administration
10/17/2013US20130273168 Solid dosage form comprising proton pump inhibitor and suspension made thereof
10/17/2013US20130273165 Carnitine granulate and methods for its production
10/17/2013US20130273164 Nanotechnology approach for inhalation therapies
10/17/2013US20130273163 Drug-delivery systems
10/17/2013US20130273162 Oral Film Containing Opiate Enteric-Release Beads
10/17/2013US20130273160 Methods and formulations for treating sialic acid deficiencies
10/17/2013US20130273159 Immediate release compositions and methods for delivering drug formulations using weak acid ion exchange resins in abnormally high pH environments
10/17/2013US20130273158 Extended release compositions of quetiapine
10/17/2013US20130273157 Orally disintegrating tablet
10/17/2013US20130273156 Oral pharmaceutical tablet for controlled release of mesalazine and process for obtaining it
10/17/2013US20130273154 Oral formulations Mimetic of Roux-en-Y gastric bypass actions on the ileal brake; Compositions, Methods of Treatment, Diagnostics and Systems for treatment of metabolic syndrome manifestations including insulin resistance, fatty liver disease, hpperlipidemia, and type 2 diabetes
10/17/2013US20130273153 Methods of Producing Stabilized Solid Dosage Pharmaceutical Compositions Containing Morphinans
10/17/2013US20130273152 Anti-abuse pharmaceutical compositions
10/17/2013US20130273146 Methods for preparation of lipid-encapsulated therapeutic agents
10/17/2013US20130273139 Transdermal delivery systems
10/17/2013US20130273138 Transdermal formulations of geranylgeranylacetone
10/17/2013US20130273136 Sustained drug delivery system
10/17/2013US20130273127 Hydrogel compositions with an erodible backing member
10/17/2013US20130273123 Colloidal Carrier System with Penetration Properties for Encapsulating Lipophilic Active Agents and Oils for Topical Use
10/17/2013US20130273121 Systems for cartilage repair
10/17/2013US20130273119 Transdermal drug administration device
10/17/2013US20130273117 Methods and systems for generating nanoparticles
10/17/2013US20130273116 Anti-fouling composition comprising an aerogel
10/17/2013US20130273115 Injectable filler
10/17/2013US20130273114 Pharmaceutical compositions of immunosuppressants
10/17/2013US20130273110 Tuberculosis Vaccine And Method Of Using Same
10/17/2013US20130273025 Oral veterinary pharmaceutical and nutraceutical compositions
10/17/2013US20130272992 Ion binding polymers and uses thereof
10/17/2013US20130272991 Ion binding polymers and uses thereof
10/17/2013US20130272990 Ion binding polymers and uses thereof
10/17/2013US20130272973 Dentifrice Containing Functional Film Flakes
10/17/2013US20130272963 Cholesterol Efflux Assay Probe Formulations, Methods of Making and Using
10/17/2013DE102012007671A1 Pellets mit hohem Wirkstoffgehalt Pellets with high active ingredient content
10/17/2013CA2809473A1 Stabilized ketorolac compositions
10/16/2013EP2650285A1 Fungicide
10/16/2013EP2650021A1 Medical device for controlled release of drug
10/16/2013EP2650019A1 Noradrenergic and specific serotonergic antidepressant-containing transdermal patch
10/16/2013EP2649993A1 Stabilizer of acetaminophen
10/16/2013EP2649990A1 Compositions with reduced dimer formation
10/16/2013EP2649989A1 Method for preparing a solid dispersion, solid dispersion obtained thereby and use thereof
10/16/2013EP2649988A1 Sustained release of antiinfective aminoglycosides
10/16/2013EP2649878A1 Methods for increasing effectiveness of antimicrobial agents in polymeric films
10/16/2013EP2648764A1 Multifunctional nanoparticles
10/16/2013EP2648760A2 Smart polymeric nanoparticles which overcome multidrug resistance to cancer chemotherapeutics and treatment-related systemic toxicity
10/16/2013EP2648759A2 Targeting kidney mesangium with nanoparticles of defined diameter
10/16/2013EP2648758A1 Bio-functionalized stimulus-responsive dissolvable peg-hydrogels
10/16/2013EP2648756A2 Targeting kidney mesangium with nanoparticles of defined diameter
10/16/2013EP2648755A1 A stable ready-to-use cetrorelix injection
10/16/2013EP2648750A2 Antibody formulation
10/16/2013EP2648738A2 Dosage and administration for preventing cardiotoxicity in treatment with erbb2-targeted immunoliposomes comprising anthracyclin chemotherapeutic agents
10/16/2013EP2648730A2 Complex formulation comprising lercanidipine hydrochloride and valsartan and method for the preparation thereof
10/16/2013EP2648722A1 Compositions for treating dermatitis and ichthyosis, and methods for treating dermatitis and ichthyosis
10/16/2013EP2648709A1 Disulfiram formulation and uses thereof
10/16/2013EP2648706A2 Compositions and methods relating to proliferative diseases
10/16/2013EP2648704A1 Anti-microbial composition
10/16/2013EP2648703A1 Pharmaceutical composition comprising trans-cinnamaldehyde and its use in the treatment of infections
10/16/2013EP2648702A2 Stable effervescent bisphosphonate formulations with rapid solubilization characteristics
10/16/2013EP2648701A1 Highly stable compositions of orally active nucleotide analogues or orally active nucleotide analogue prodrugs
10/16/2013EP2648700A1 Pharmaceutical composition comprising dutasteride
10/16/2013EP2648699A2 Dosage form
10/16/2013EP2648698A1 Liposomal formulation of dalcetrapib
10/16/2013EP2648697A1 Methods for forming miniemulsions and use thereof for delivering bioactive agents
10/16/2013EP2648696A1 New form of administration of enkephalinase inhibitor
10/16/2013EP2648552A1 Barley protein microcapsules
1 ... 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 ... 2991